Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep 15;59(6):883-7.
doi: 10.1093/cid/ciu401. Epub 2014 Jun 9.

The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women

Alys Adamski  1 , Rebecca A Clark  2 , Leandro Mena  3 , Harold Henderson  3 , Judy Levison  4 , Norine Schmidt  1 , Hirut T Gebrekristos  1 , David H Martin  2 , Patricia Kissinger  1
Affiliations

The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women

Alys Adamski et al. Clin Infect Dis. .

Abstract

Objective: Among women who are human immunodeficiency virus positive (HIV+), both prevalent and persistent infections with Trichomonas vaginalis (TV) are common. TV has been shown to increase vaginal shedding of HIV, which may influence HIV sexual and perinatal transmission, making prevention important. In 1 cohort of HIV+ women in Kenya, antiretroviral therapy (ART) use, mostly nevirapine based, was associated with lower cure rates of TV for single-dose therapy. Our goal was to repeat this study in a US-based cohort of HIV+/TV+ women and compare outcomes to those with multidose therapy.

Methods: A secondary data analysis was performed on a multicentered cohort of HIV+/TV+ women who were randomized to single-dose (2 grams) or 7-day (500 mg twice daily) multidose metronidazole (MTZ) treatment. Test of cure visit, via culture, occurred 6-12 days after treatment completion. Information was collected on sex partner treatment and sexual exposures. Persistent TV infection rates were compared for women on ART at baseline vs not on ART.

Results: Of the 226 women included, those on ART had more treatment failures than women not on ART (24/146 [16.4%] vs 5/80 [6.3%]; P = .03). When stratified by treatment arm, more treatment failures were seen in the single-dose arm (17/73 [23.3%] vs 3/39 [7.7%]; P = .05) than in the multidose arm (7/73 [9.6%] vs 2/41 [4.8%]; P = .39).

Conclusions: ART usage was associated with a higher TV persistent infection rate among those receiving the single-dose treatment, but not the multidose, providing more evidence that multidose should be the preferred treatment for HIV+ women.

Keywords: HIV; Trichomonas vaginalis; antiretroviral; metronidazole.

PubMed Disclaimer

Comment in

References

    1. World Health Organization. Geneva, Switzerland: World Health Organization; 2011. Prevalence and incidence of selected sexually transmitted infections. Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and Trichomonas vaginalis. Methods and results used by WHO to generate 2005 estimates.
    1. Magnus M, Clark R, Myers L, Farley T, Kissinger PJ. Trichomonas vaginalis among HIV-infected women: Are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity? Sex Transm Dis. 2003;30:839–43. - PubMed
    1. Clark RA, Theall KP, Amedee AM, Kissinger PJ. Frequent douching and clinical outcomes among HIV-infected women. Sex Transm Dis. 2007;34:985–90. - PubMed
    1. Kissinger PJ, Dumestre J, Clark RA, et al. Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. Sex Transm Dis. 2005;32:227–30. - PubMed
    1. Seth P, Wingood GM, Diclemente RJ. Exposure to alcohol problems and its association with sexual behaviour and biologically confirmed Trichomonas vaginalis among women living with HIV. Sex Transm Infect. 2008;84:390–2. - PubMed

Publication types

MeSH terms